Showing results (891-900 of 950) with videos related to

Sort By:
Pageof 95
Molecular Diagnosis & Therapy|December 8, 2022
Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable MarkersGiang T Lam, Sarita Prabhakaran, Alexandra Sorvina, et al.
Clinical and Translational Science|April 22, 2025
Care Team Attributes Predict Likelihood of Utilizing Pharmacogenomic Information During Inpatient PrescribingZhong Huang, Matthew Jack, Kevin J O'Leary, et al.
Clinical and Translational Science|December 29, 2018
The ACCOuNT Consortium: A Model for the Discovery, Translation, and Implementation of Precision Medicine in African AmericansPaula N Friedman, Mohammed Shaazuddin, Li Gong, et al.
International Journal of Molecular Sciences|July 2, 2021
An Overview of the Role of Long Non-Coding RNAs in Human ChoriocarcinomaRiccardo Di Fiore, Sherif Suleiman, Ana Felix, et al.
International Journal of Molecular Sciences|January 24, 2013
Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screeningAlexandros Laios, Bashir M Mohamed, Lynn Kelly, et al.
Pharmacogenetics and Genomics|February 2, 2023
Implementation of pharmacogenomics into inpatient general medicineThomas Chen, Peter H O'Donnell, Merisa Middlestadt, et al.
International Journal of Epidemiology|November 22, 2005
Measles outbreak in the Republic of the Marshall Islands, 2003Terri B Hyde, Gustavo H Dayan, Justina R Langidrik, et al.
Cell Death & Disease|October 20, 2017
CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchyBrendan Ffrench, Claudia Gasch, Karsten Hokamp, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 11, 2008
Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patientsRichard J Flavin, Paul C Smyth, Stephen P Finn, et al.
Frontiers in Cell and Developmental Biology|December 25, 2023
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapyTanya E Kelly, Cathy L Spillane, Mark P Ward, et al.
Pageof 95